| Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma (NCT02098538) | Memorial Sloan Kettering Cancer Center | 2014-03-01 |
| Study of Ruxolitinib in Colorectal Cancer Patients (NCT02119676) | Incyte Corporation | 2014-03-01 |
| A Phase II Study of Ziv-aflibercept in Combination With Capecitabine/Oxaliplatin (XELOX) Chemotherapy in the Front-Line Treatment of Patients With Metastatic Colorectal Cancer (NCT02079220) | James J Lee | 2014-03-01 |
| Study of the Combination of Anti-OX40 and Ipilimumab in Patients With Metastatic Melanoma (NCT01689870) | Ludwig Institute for Cancer Research | 2014-03-01 |
| 68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors (NCT02038738) | Ochsner Health System | 2014-03-01 |
| Mecillinam for Treatment of Genital Chlamydia Infection (NCT02083276) | Oslo University Hospital | 2014-03-01 |
| Nifedipine Treatment on Uterine Contractility in IVF (NCT02072291) | Hadassah Medical Organization | 2014-03-01 |
| Ph II Trial of Carboplatin and Pemetrexed With or Without AZD1775 for Untreated Lung Cancer (NCT02087241) | AstraZeneca | 2014-03-01 |
| A Phase I/IIa Study of the Safety, Immunogenicity and Efficacy of FMP2.1/AS01B, an Asexual Blood-Stage Vaccine for Plasmodium Falciparum Malaria (NCT02044198) | University of Oxford | 2014-03-01 |
| Zinc Gel and Epidermal Regeneration in Healthy Human Volunteers (NCT02116725) | Bispebjerg Hospital | 2014-03-01 |
| Civamide Nasal Solution for Postherpetic Neuralgia of the Trigeminal Nerve (NCT01886313) | Winston Laboratories | 2014-03-01 |
| Safety and Efficacy Study of R932348 Ophthalmic Solution in Chronic Ocular Graft Versus Host Disease Patients(DROPS-2) (NCT02040623) | Rigel Pharmaceuticals | 2014-03-01 |
| Rituxan and Abraxane for the Treatment of Patients With Inoperable Stage III and IV Malignant Melanoma (NCT02142335) | California Cancer Assocaties for Research & Excellence | 2014-03-01 |
| Efficacy Study of IV Ibuprofen vs IV Acetaminophen Post Surgical Extraction (NCT02133326) | Tufts University School of Dental Medicine | 2014-03-01 |
| Amiloride Hydrochlorothiazide as Treatment of Acute Inflammation of the Optic Nerve (NCT01879527) | Medical University of Vienna | 2014-03-01 |
| Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus (NCT02093221) | Grifols Therapeutics LLC | 2014-03-01 |
| ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme (NCT01903330) | Epitopoietic Research Corporation | 2014-03-01 |
| Efficacy Evaluation of Intravenous Brivaracetam and Phenytoin in Subjects With Nonconvulsive Electrographic Seizures (NCT02088957) | UCB BIOSCIENCES, Inc. | 2014-03-01 |
| ATX-MS-1467 in Multiple Sclerosis (NCT01973491) | Merck KGaA, Darmstadt, Germany | 2014-02-28 |
| A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease (NCT02006472) | Prilenia | 2014-02-28 |
| Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Renal Insufficiency (NCT02045017) | Celgene | 2014-02-28 |
| Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) (NCT01993186) | Ultragenyx Pharmaceutical Inc | 2014-02-28 |
| RTA 408 Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain Following Ocular Surgery (NCT02065375) | Biogen | 2014-02-28 |
| A Study of Lebrikizumab (RO5490255) in Participants With Severe Oral Corticosteroids (OCS) Dependent Asthma (NCT01987492) | Hoffmann-La Roche | 2014-02-28 |
| Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients (NCT02035787) | UNC Lineberger Comprehensive Cancer Center | 2014-02-27 |
| Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCR and 4-1BB Signaling Domains in Patients With Chemotherapy Resistant or Refractory Acute Lymphoblastic Leukemia (NCT02030847) | University of Pennsylvania | 2014-02-27 |
| Avalglucosidase Alfa Extension Study (NCT02032524) | Genzyme, a Sanofi Company | 2014-02-27 |
| Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of rhHNS Administration Via an IDDD in Pediatric Patients With Early Stage MPS IIIA Disease (NCT02060526) | Shire | 2014-02-26 |
| Crossover Clinical Trial, Randomized, Double Blind, Placebo Controlled Trial (NCT04983160) | Maimónides Biomedical Research Institute of Córdoba | 2014-02-26 |
| A Global Study to Assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer (NCT02087423) | AstraZeneca | 2014-02-25 |
| Optimizing Pazopanib Exposure in RCC Patients (NCT02089802) | Interessenverband zur Qualitätssicherung der Arbeit niedergelassener Uro-Onkologen in Deutschland e. | 2014-02-25 |
| Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis Participants (NCT02065700) | Lakefront Biotherapeutics NV | 2014-02-25 |
| Safety and Tolerability of Antiplaque Chewing Gum in a Gingivitis Population (NCT01877421) | U.S. Army Medical Research and Development Command | 2014-02-25 |
| A Pharmacokinetics/Dynamics Ib Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy (NCT02522234) | EVIVE Biotechnology | 2014-02-25 |
| A Study of GWP42003 as Adjunctive Therapy in the First Line Treatment of Schizophrenia or Related Psychotic Disorder (NCT02006628) | Jazz Pharmaceuticals | 2014-02-25 |
| Platelet-Rich Plasma (PRP) Injection for the Treatment of Chronic Patellar Tendinopathy (NCT01843504) | University of Wisconsin, Madison | 2014-02-25 |
| A Study Into Pain Relief Given by ASP8477 for Peripheral Neuropathic Pain (Either Post-herpetic Neuralgia or Painful Diabetic Peripheral Neuropathy) and Its Safety (NCT02065349) | Astellas Pharma Europe B.V. | 2014-02-24 |
| A Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy or Immunotherapy in Participants With Non-small Cell Lung Cancer (MK-3475-021/KEYNOTE-021) (NCT02039674) | Merck Sharp & Dohme LLC | 2014-02-21 |
| Immunotherapy Using 41BB Selected Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma (NCT02111863) | National Cancer Institute (NCI) | 2014-02-21 |
| Study to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the Brain (NCT02039947) | Novartis Pharmaceuticals | 2014-02-21 |
| An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome (NCT02036853) | Adrian Lacy | 2014-02-20 |
| Clinical Investigation of Galnobax® for the Treatment of Diabetic Foot Ulcers (NCT01113515) | Novalead Pharma Private Limited | 2014-02-20 |
| Auranofin in Decreasing Pain in Patients With Paclitaxel-Induced Pain Syndrome (NCT02063698) | Mayo Clinic | 2014-02-19 |
| Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential Thrombocythemia (NCT01998828) | Sierra Oncology LLC - a GSK company | 2014-02-19 |
| Vismodegib in Basal Cell Carcinomas (BCC) Chemoprevention (NCT02067104) | University of Arizona | 2014-02-17 |
| Safety, Tolerability and Immunogenicity of NBP607QIV in Healthy Adult Volunteers (NCT03826719) | SK Chemicals Co., Ltd. | 2014-02-17 |
| Switch to Ticagrelor in Critical Limb Ischemia Anti-platelet Study (NCT02091921) | University of Southern California | 2014-02-16 |
| A Study to Evaluate the Efficacy and Safety of CT-P27 in an Influenza Challenge Model (NCT02071914) | Celltrion | 2014-02-15 |
| Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer (NCT02059265) | National Cancer Institute (NCI) | 2014-02-14 |
| A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures. (NCT01969851) | UCB Pharma | 2014-02-13 |
| The TRansendocardial Stem Cell Injection Delivery Effects on Neomyogenesis STudy (The TRIDENT Study) (NCT02013674) | Joshua M Hare | 2014-02-13 |
| Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast Cancer (NCT02049957) | Calithera Biosciences, Inc | 2014-02-13 |
| Safety Evaluation of Gene Therapy in Leber Hereditary Optic Neuropathy (LHON) Patients (NCT02064569) | GenSight Biologics | 2014-02-13 |
| Investigation of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of Oral Danirixin in Symptomatic COPD Subjects With Mild to Moderate Airflow Limitation at Risk for Exacerbations (NCT02130193) | GlaxoSmithKline | 2014-02-13 |
| Myrcludex B Plus Pegylated Interferon-alpha-2a in Patients With HBeAg Negative HBV/HDV Co-infection (NCT02637999) | Hepatera Ltd. | 2014-02-13 |
| Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome (NCT02019706) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2014-02-12 |
| Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer (NCT02119650) | Incyte Corporation | 2014-02-11 |
| A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD19 for Relapsed/Refractory CD19+ Leukemia (NCT02028455) | Seattle Children's Hospital | 2014-02-11 |
| Analysis of the Modulation of Serum Hepcidin Level in Response to Iron Oral Intake: Potential Interest for the Differential Diagnosis Between Ferroportin Disease and Dysmetabolic Hepatosiderosis. (NCT01949467) | Rennes University Hospital | 2014-02-10 |
| 15141 Fixed Dose Correction / naïve and Pre Dialysis (Europe and Asia Pacific) (NCT02021370) | Bayer | 2014-02-10 |
| Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia (NCT01885689) | City of Hope Medical Center | 2014-02-10 |
| FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma (NCT02037048) | Case Comprehensive Cancer Center | 2014-02-10 |
| Abiraterone Acetate in Combination With Docetaxel After Disease Progression to Abiraterone Acetate in Metastatic Castration Resistant Prostate Cancer. (NCT02036060) | Spanish Oncology Genito-Urinary Group | 2014-02-07 |
| T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive (NCT02111850) | National Cancer Institute (NCI) | 2014-02-07 |
| Study of Human Non-Shivering Thermogenesis and Basal Metabolic Rate (NCT01950520) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2014-02-07 |
| A Study of DNIB0600A in Comparison With Pegylated Liposomal Doxorubicin (PLD) in Participants With Platinum-Resistant Ovarian Cancer (PROC) (NCT01991210) | Genentech, Inc. | 2014-02-06 |
| A Study of UX007 (Triheptanoin) in Participants With Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) (NCT01886378) | Ultragenyx Pharmaceutical Inc | 2014-02-06 |
| Standard of Care +/- Midostaurin to Prevent Relapse Post Stem Cell Transplant in Patients With FLT3-ITD Mutated AML (NCT01883362) | Novartis Pharmaceuticals | 2014-02-06 |
| Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen OIT (NCT01987817) | Aimmune Therapeutics, Inc. | 2014-02-06 |
| Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy (NCT02099864) | OHSU Knight Cancer Institute | 2014-02-05 |
| Donor-Derived Viral Specific T-cells (VSTs) (NCT02048332) | Children's Hospital Medical Center, Cincinnati | 2014-02-05 |
| Vaccine Therapy With or Without Polysaccharide-K in Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy (NCT01922921) | University of Washington | 2014-02-05 |
| Phase IIa Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCRz and 4-Signaling Domains in Patients With Chemotherapy Relapsed or Refractory CD19+ Lymphomas (NCT02030834) | University of Pennsylvania | 2014-02-05 |
| Targeted Busulfan, Fludarabine, Etoposide Conditioning Regimen for HSCT in Childhood and Adolescent ALL. (NCT02047578) | Seoul National University Hospital | 2014-02-05 |
| Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting (NCT02004262) | Aduro Biotech, Inc. | 2014-02-05 |
| Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine (NCT01845337) | University of Edinburgh | 2014-02-05 |
| Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT (NCT01962415) | Paul Szabolcs | 2014-02-04 |
| Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy (NCT02024932) | Novartis Pharmaceuticals | 2014-02-04 |
| Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations (NCT01989546) | National Cancer Institute (NCI) | 2014-02-04 |
| Cryoablation, Radiofrequency Ablation, or Microwave Ablation in Treating Patients With Metastatic Sarcoma Stable on Chemotherapy (NCT01986829) | Washington University School of Medicine | 2014-02-03 |
| Study of the Vascular Effects of Serelaxin (NCT01979614) | Novartis Pharmaceuticals | 2014-02-03 |
| Effect of Mixed On-line Hemodiafiltration on Circulating Markers of Inflammation and Vascular Dysfunction (NCT03202212) | A.O.U. Città della Salute e della Scienza | 2014-02-03 |
| CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT02019069) | Rondeep Brar | 2014-02-03 |
| Study to Assess the Efficacy and Safety of Treatment of Articular Cartilage Lesions With CartiLife® (NCT03545269) | Biosolution Co., Ltd. | 2014-02-03 |
| Remifentanil for General Anesthesia in the Context of Immaturity (NCT02029898) | University Hospital, Rouen | 2014-02-02 |
| Striatal Effective Connectivity to Predict Treatment Response in Cocaine Misuse (NCT02080819) | Virginia Commonwealth University | 2014-02-01 |
| Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery (NCT02042443) | National Cancer Institute (NCI) | 2014-02-01 |
| Antidepressant Effects of Ayahuasca: a Randomized Placebo Controlled Trial in Treatment Resistant Depression (NCT02914769) | Universidade Federal do Rio Grande do Norte | 2014-02-01 |
| A Study to Assess the Efficacy of XEN-D0501 in Reducing the Cough Frequency in Patients With COPD (NCT02233686) | Xention Ltd | 2014-02-01 |
| A Phase I/II Study of [124I]mIBG PET/CT in Neuroblastoma (NCT02043899) | Cancer Research UK | 2014-02-01 |
| Antibiotics and Hydroxychloroquine in Crohn's (NCT01783106) | Royal Liverpool University Hospital | 2014-02-01 |
| The Effects of Two Volitional Interventions to Improve Oral Health Behaviour Among Iranian Adolescents (NCT02066987) | Qazvin University Of Medical Sciences | 2014-02-01 |
| Efficacy and Safety of Tazarotene Gel in Nail Psoriasis (NCT02235480) | Almirall, S.A. | 2014-02-01 |
| Evaluation of the High Dose of Icotinib in Advanced Lung Cancer Patients After Failure of Target Therapy (NCT01963195) | Anhui Medical University | 2014-02-01 |
| Nitazoxanide Versus Placebo for the Treatment of Hospitalized Subjects With Severe Acute Respiratory Illness (NCT02057757) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-02-01 |
| TUSC2-nanoparticles and Erlotinib in Stage IV Lung Cancer (NCT01455389) | Genprex, Inc. | 2014-02-01 |
| LDE225 for Patients With PTCH1 or SMO Mutated Tumors (NCT02002689) | Novartis Pharmaceuticals | 2014-02-01 |
| Cancer Stem Cells Vaccine Therapy in Treating Hepatocellular Cancer Patients (NCT02089919) | Fuda Cancer Hospital, Guangzhou | 2014-02-01 |
| To Determine the Minimum Amount of Alternaria Alternata Allergen Extract Producing a Positive Skin Reaction. (NCT01984528) | Laboratorios Leti, S.L. | 2014-02-01 |
| Chemo Sensitization Before Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia in Complete Remission (NCT02605460) | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2014-02-01 |